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Figure 1. Sealed Radon applicators 
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The history of Medical Physics goes back to the discovery of X-rays in 1895 and that of Radium 
in 1898. In Chicago Dr. Emil Grubbe was the first 
American physician to use x-rays to treat cancer, 
beginning in 1896. From initial therapeutic 
experiments with x-rays, a new field of therapy was 
born, referred to as röntgenotherapy.  Radium was 
soon recognized as an effective tool for cancer 
treatment. Two methods of applying it were used: 
radon gas, sealed in glass applicators (fig.1) or radium 
salts, sealed in tubes or needles. Cancer of the uterine 
cervix was treated with radium tubes up through the 
70s.  
 
In the mid-1900s, orthovoltage X-rays, Cobalt-60 and Caesium-137 therapy units came into use.  
Orthovoltage units are not suitable to treat deep-seated tumors, therefore the use of Radium 
implants. However, orthovoltage beams became the standard for radiobiological studies. 
Radiologists used them for treatments but were eager to have higher energy beams. In 1929, the 
Van de Graaff generator was invented and in 1937 Harvard Medical School was the first to 
acquire one producing 2 MV X-rays.  
 
At the International Congress of Oncology in Paris in 1922, Henri Coutard presented evidence 
that laryngeal cancer could be treated without disastrous side effects. By 1934, he had developed 
a protracted, fractionated protocol. The dosage and fractionation were designed to create a severe 
but recoverable acute mucosal reaction. By 1935, Doctors everywhere began following it. 
 
In 1949, Harold Johns obtained two Cobalt-60 sources for use in prototype therapy units. He 
collected extensive depth-dose data which would become the world standard. The first patient 
was treated with Cobalt-60 radiation in 1951. Cobalt units are the most reliable radiation therapy 
machines because of their mechanical and electric simplicity. They are still used all over the 
world. 
 
In 1946, at the end of WW II, the US Congress passed the “Atomic Energy Act”, which provided 
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Figure 2. Argonne Cancer Research Hospital (ACRH)  
[Attached to Billings Hospital] 
for the construction of the Argonne Cancer Research Hospital (ACRH) (fig.2).  The 50-bed 
hospital would be located at the campus of the University of Chicago which would operate it for 
the Atomic Energy Commission.  It was estimated that the 6-story building would cost 
proximately $3,500,000.  When it opened, in 1953, it was the first hospital in the US devoted to 
the use of radiation primarily for research in the treatment and diagnosis of cancer. 
 
          
 
 
 
Lester Skaggs received his PhD in Nuclear Physics from the UoC in 1939.  He spent the 
following two years as a postdoctoral fellow at the 
University at the same time holding a part-time 
job at the nearby Michael Reese Hospital. The 
radiation oncologist there, Dr. Erick Uhlmann, 
was interested in acquiring a betatron recently 
invented by Donald Kerst (fig.3).  It uses 
electromagnetic induction to accelerate electrons 
in a doughnut shaped vacuum chamber, thus 
circumventing the high voltage insulation problem 
associated with X-rays units higher than 250 KV.  
Dr. Uhlmann was interested in 40 MeV electrons. 
However, because of World War II, the project 
did not get off the ground. Skaggs was drafted and 
went to Los Alamos, New Mexico, to work on the Manhattan Project (for the atomic bomb). 
 
Returning to Chicago at the end of the war, he was hired back by Michael Reese Hospital and, in 
1945, went to the University of Illinois in Urbana, to design the 40-MeV medical betatron under 
the guidance of Kerst. Soon after, a physics graduate student was diagnosed with glioblastoma 
multiformae. The surgeon recommended follow up with radiation.  The radiologist at the local 
Fig 3. Dr. Kerst with the 2.5 and 22 MeV 
betatrons (at the University of Illinois) 
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Figure 5. Kerst and Skaggs with the doughnut.  
Skaggs points at the electron beam exit port. 
Med. Phys. 2, p297, 1975 
 
Carle Clinic Hospital, Dr. Henry Quastler agreed to treat him. With guidance from Kerst and 
Quastler, a team of eight young physicists (John Laughlin, Gale Adams, Bill Koch, Lester 
Skaggs, Larry Lanzl, Elizabeth Lanzl, Al Hanson, and Gerry Almy,) took on the challenge.  
They succeeded in extracting the circulating electron beam from the betatron Kerst had built for 
physics experiments (fig.4). The beam hit 
an external target thus producing 22 MV 
gamma-rays. (fig.5). They made a 
collimator of 100 thin lead sheets 
alternating with insulating sheets of paper 
to suppress eddy currents which would 
interfere with the circulating electron 
beam. They designed and built a beam 
intensity flattener since the natural 
distribution of photon intensity was 
peaked forward (fig.6&7). Depth-dose 
distributions along the central axis were 
obtained with a thimble chamber in water.  
Isodose distributions were measured with 
photographic film in pressed wood 
Figure 4. 
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phantoms (fig.8). Their approach for transmission 
monitoring of the beam was to measure the 40 min 
activity induced in a thin zinc foil calibrated by 
comparison with a 25-r Victoreen condenser 
chamber embedded in a standard phantom. The 
output at 1 meter was 50r per min. This was in 
turn calibrated relative to the conventional 200-
KV X-rays by means of quantitative biological 
tests resulting in an RBE for the high energy beam 
of 0.75. They developed a treatment plan 
consisting of 20 non-coplanar fields.  With Quastler’s guidance the physics shop designed and   
built a swiveling chair and an immobilization device to position the patient so that beams could 
be entered from many directions. This was the first stereotactic radiation treatment. Their work 
was published in a current medical journal (fig. 9). 
 
 
 
 
All this was done after regular hours and the job was completed within two weeks!  This was the 
first time high-energy photons were used for radiation therapy. An autopsy showed no residual 
cancer at the tumor site.  This was also a first for this group of young scientists, trained in 
Figure 8.  Isodose Distributions. 
22-MV beam 9cm dia. at 75 cm. 
Am. J. Roentgenology, Radium Ther. 
v.60 p.153, 1948 
 
Figure 7.  Am. J. Roentgenology, 
Radium Ther. v.60 p.153, 1948 
Figure 6.  22-MV beam characteristics 
Figure 9. 
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Lanzl, Skaggs, Machinist Dr. Carpenter, Therapist, Patient, Lanzl 
nuclear physics, who worked out and delivered a sophisticated treatment plan without previous 
experience. This experience, however, marked the start of their careers in Medical Physics. 
 
John Laughlin joined the faculty of the U of I School of Medicine in Chicago continuing the 
clinical applications of the betatron.  Later he moved to Memorial Hospital in New York City. 
Gail Adams went to the U of CA, San Francisco, to engineer a 70-MeV synchrotron for clinical 
use, he later moved to the U of Oklahoma. Both were part of the three-man team founders of the 
AAPM.  Bill Koch went to the National Bureau of Standards (NBS) specializing in calibration 
measurements of high energy radiation fields. Lester Skaggs spent another year at the U of I to 
complete the design of the betatron, later he went to the U of C and brought the Lanzls with him. 
Al Hanson and Gerry Almy remained in the Physics Department at U of I. 
 
When I came to the U of I in 1960, my thesis research used the same 22 MV betatron. Al Hanson 
was my advisor and Gerry Almy was the Department Chairman. Later in 1971 I joined the 
Skaggs-Lanzl group at the U of C.  
 
With the passing of the Atomic Energy Act, the radiation oncologists at the U of C also wanted a 
betatron. So in 1948, Skaggs was offered an Assistant Professorship at the U while Michael 
Reese Hospital was having troubles raising funds for its betatron. A deal was worked out that 
Skaggs would accept the appointment but remain in Urbana to complete the design that took 
another year. In 1949, returning to Chicago, he was put in charge of developing the therapy 
facilities at the ACRH which was to have a 2-MV Van de Graaff, an isocentric Cobalt unit, a 
betatron, and electronics and machine shops. By then Larry Lanzl had gotten his PhD and was at 
Argonne National Laboratory (ANL). Skaggs brought him in as his assistant. The following year 
they hired a recent graduate, Marty Rozenfeld, who went to England to learn clinical physics. 
 
Skagg’s first project was to design and build a 2,000- Ci Co rotational therapy unit (fig.10).  The 
cobalt source was activated at the Materials Test Reactor in Idaho; it was small in size with high     
   
 
 Figure 10.  2,000-Ci Isocentric Co-60 unit, SAD = 80cm. 
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specific activity, yielding an intense beam with minimal penumbra. It came in the form of a 
number of pellets which were assembled at the Argonne facilities for handling radioactive 
materials. The 800 lb. depleted uranium metal shield was also cast at Argonne.  Uranium was 
chosen since it is 68% denser than lead thus reducing the size of the source shielding.      
 
The gantry and controls were built in the Physical Sciences machine shop at the U of C (fig.11).   
The Cobalt unit was completed in 1956.  The largest field size was 20x20cm2 at 80cm SAD.  The 
unit was in operation for over 30 years. This was the first rotational Co-60 treatment machine in 
the US.  
  
   
 
 
 
While the work on the Co-unit was proceeding, as soon as the building was completed, a 2-MV 
Van de Graaff was purchased (fig.12). It was installed hanging from the ceiling in a vault, next to 
the Co unit.  It could move vertically as well as swing from pointing down to horizontal. The 
patient was either sitting on a chair or lying on a table.  Both, chair and table, could rotate on a 
vertical axis. The VdG was first used for H&N disease patients, later for other diseases as well as 
for Hodgkins with the patient lying on the floor to achieve larger fields. It was decommissioned 
in 1980, and the room was redesigned for a Varian Clinac 2500. 
 
Prior to the availability of megavoltage x-rays and electrons, the primary concern of medical 
physicists was the uses of radioactive nuclides.  Large selection of Radium tubes and needles 
were in stock in many hospitals.  Treatments were prescribed in units of mgRa hrs. As computers 
became available, orthogonal films of an implant were taken in the OR, the coordinates were 
sent by teletype to a computer downtown which returned the dose calculations in a few hours.  
 
In the mid 1940’s, medical physicists in the metropolitan New York City area started regular 
Lanzl Co-60 unit and dose plotting 
 
Controls and Lead Glass Observation Window 
Figure 11.  2,000-Ci Co-60 unit 
 
 7 
The first patient treated with electrons for ↑ 
 retinoblastoma in 1957 
Figure 13. Stanford University’s First Medical Lineac 
   Dr. Henry Kaplan showing the insides of the 6-MeV 
↓ lineac developed to treat cancer 
meetings to compare instrumentation and measurements of the quantity of radioactivity used. 
Besides Radium, the clinical uses of Iodine-131, Phosphorus-32 and Yttrium-90 were being 
actively explored in Nuclear Medicine.  Agreement on the amount of activity administered by 
the various groups was essential. Such meetings led to the ‘‘New York milliCurie,’’ and to the 
founding of the “Radiological and Medical Physics Society”- RAMPS which, in turn, led to the 
creation of the AAPM in 1959 with a membership of 50 physicists. Today the membership is 
7,826! 
 
 
 
 
As Skaggs started to work on the 
betatron, he ran into a snag.  
Michael Reese Hospital claimed 
ownership of the design which was 
done while he was on their payroll. 
So the U of C team turned to a new 
approach.  The Varian brothers in 
CA had invented the Klystron, a 
high power microwave 
amplification tube that became a 
critical component of the radars 
used in the War. In 1948, Varian 
Associates Corporation was 
founded to market this invention. 
At the same time (fig.13), the 
Engineering group at Stanford 
University joined efforts with 
Varian to design and build a 6-MeV electron Lineac for their Radiation Oncologist, Dr. Henry 
Kaplan.  
Controls and Lead Glass 
 ↓ Viewing Window 
Figure 12.  2-MV Van de Graaff device patient set up 
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Figure 14. 5-50 MV Lineac Power Vault 
Figure 15. 5-50 MV Lineac Gantry beam transport 
Figure 16. 5-50 MeV Lineac rotating and 
scanning gantry.  View of the Lineac treatment 
room.  Dr. Lanzl is controlling the gantry 
So, in 1949, Skaggs approached the 
Stanford group with the proposal of 
designing and building a 5-50 MeV 
Lineac. They agreed to sell him the basic 
components and he arranged to have the 
machine built by High Voltage 
Engineering in Cambridge, MA, 
manufacturers of the Van de Graaffs.  
His design called for two wave guides in 
series, each powered by a 20 Megawatts 
klystron.  Both wave guides accelerated 
electrons to 25 MeV, but, by changing 
the phase of the second relative to the 
first one, the electron energy could be 
varied continually from 5 to 50 MeV. The 
accelerator was completed and tested in 
Cambridge, transported by truck to 
Chicago and installed in 1954.  It was 
producing a fixed horizontal beam, ½ cm 
in diameter. Each accelerating wave guide 
was 16 ft. long and, with the auxiliary 
equipment, occupied the vault designed 
for the betatron (fig.14).  Skaggs then 
contracted Varian to design and build the 
gantry consisting of three magnets 
(fig.15) to bend, rotate and scan the 
electron beam which could cover, in a raster 
mode, an irregularly shaped field up to a 
20x20cm2 area, mechanically defined by a 
custom template cut out of a sheet of Lucite.  
The gantry was delivered in 1957 (fig.16). It 
took another two years of design, 
engineering, construction, and testing to 
complete the Lineac which was built at a cost 
of $450,000.  This was the first medical high 
energy electron Lineac (fig.17). An elaborate 
program of beam energy calibration by 
magnetic deflection and absolute output 
measurements with a specially designed 
Faraday cup was the thesis research project 
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Skaggs at the Lineac controls Therapist, Dr. Mel Griem, Physics Tech. 
Figure 18. 
Measurements for 
treatment planning. 
of the first MS student in Medical Physics. The first patient was treated in 1959, ten years after 
the start of the project.  Later, a technique developed at Stanford for the treatment of Mycosis 
Fungoides was implemented.  For this application, a scattering foil and flattening filter are used 
to spread the horizontal electron beam.  The patient stands at 4m from the source on a platform, 
which can rotate on its vertical axis in steps of 60° to receive an anterior, a posterior and four 
oblique fields. Each field is composed of a dual angulated beam, one with its axis at 14° up and 
the other 14° down, so that a uniform dose is achieved over the entire height and width of the 
patient in a vertical plane.  Patients came for treatments from as far as Texas.  The Lineac was in 
operation for over 30 years. 
 
 
 
To foster the growth of Medical Physics, Skaggs and Lanzl took the lead 
in developing the first Medical Physics graduate training program in the 
US at the MS level in the mid 50’s, expanded it to PhD in the 60’s and 
added postdoctoral training in the 70’s. I was the first post-doctoral 
research trainee starting in 1971. 
 
In those years, clinical dosimetry at the U of C was in its infancy. Output 
was measured with Victoreen condenser chambers calibrated in 
Roentgens at the NBS, isodose distributions were measured with film in 
pressed wood or in water with custom-made ion chambers attached to a 
one dimensional scanner. All calculations were done by hand using tables 
and various plots of isodose distributions.  To produce a treatment plan, 
the contour of the patient at the level of the central axis was obtained in 
simulation by the therapist using a lead wire and traced on a sheet of 
paper (fig 18).  The dosimetrist then traced the isodose curves for each 
beam and then created a composite distribution by adding the 
Figure 17. Routine operation of the Lineac required both a physics and a therapy technician. 
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Figure 19. 2D Isodose Hand Calculation. 
Fletcher’s Textbook of Radiotherapy 
Figure 20. 2D Compensator. Fletcher’s Textbook of Radiotherapy 
Figure 21. Hall, Radiobiology for the Radiologist. 
Relative Biologic 
Effectiveness (RBE) = 4 
Oxygen Enhancement 
Ratio 
contributions of each beam (fig 19). Elaborate 
filters were built to compensate for missing 
tissue (fig 20). Both dosimetrist and chief 
therapist were trained in England.  When, in 
1970, the first computer was purchased, a 
PDP11, it was used for patient records and, as 
such, it did not have floating point processor. A 
treatment-planning computer was only acquired 
in the 80s and treatment planning software was 
developed in house first in two and later CT-
based in three dimensions.    
 
 
Based on radiobiological studies it was suggested that high LET 
radiation may be more effective in cancer treatment than photons 
(fig.21).  In 1961, a pilot neutron therapy program was initiated 
at the Hammersmith Hospital in London.  Soon after, three 
facilities in the US started neutron therapy using existing physics 
research cyclotrons. By 1969, 
there appeared to be impressive 
local tumor control on patients 
treated with neutrons.  
 
That same year, the ACRH got 
funding for a small medical 
cyclotron to produce short lived 
isotopes for diagnostic and 
nuclear medicine and for the 
eventual development of a 
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Figure 22. Neutrons time of flight spectra 
Figure 23. ACRH neutron facility floor 
plan. Radiology, v.111, p.471, 1974 
Figure 24. Neutron 
energy spectra 
neutron therapy beam.  The beams available were 
16 MeV protons, 8 MeV deuterons and 22 MeV 
alphas. Dr. Paul Harper, grandson of the founder 
of the U of C, headed an active research program 
in Nuclear Medicine. A number of short lived 
positron emitters were produced for studies with 
a prototype PET scanner.  Sophisticated 
collimators used with the Anger camera in the 
detection of radiation from radioactive isotopes 
were designed and built in house. 
 
When I joined the U of C in 1971, there was a 
high interest to develop the neutron capability of 
the cyclotron.  So I was assigned to the project. 
Beryllium was the chosen target and I proceeded 
to make neutron spectral measurements by time of 
flight techniques at the Tandem Van de Graaff at 
ANL for the beams available on the cyclotron 
(fig.22).   Measurements were obtained for each 
reaction in the forward direction and at a number 
of angles. These showed that the deuteron beam 
was the most favorable.  We also observed that 
while the fast neutrons have a forward peaked 
angular distribution, the gamma component is 
isotropic. We proceeded with the design and 
construction of the facility. (fig.23). A Monte 
Carlo computer code developed at ANL was used in the design of 
the shielding and collimator. The measured neutron spectra and 
angular distributions were used in the input.  
 
In 1974 we learned that a high-pressure deuterium gas target was in 
use at the German Cancer Research Center in Heidelberg, 
Germany. Since the deuteron on deuterium reaction was known to 
produce a neutron beam superior to that from the deuteron on 
beryllium, (fig.24), we decided to follow the German design but to 
improve on it by cooling the gas at liquid nitrogen temperature 
(78oK) which would increase its density by a factor of 3. We 
contracted a cryogenic consulting firm for the design, construction 
and installation of the target system (fig.25). The quality of the 
neutron beam would be superior in penetration to that at the 
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Hammersmith Hospital.  Progress was steady but slow due to lack of funding. The first patient 
was treated in 1981.  We had a fixed horizontal beam and used the treatment chair from the 
decommissioned Van de Graaff.  The neutron facility proved to be reliable and was used for 10 
yrs. It was the first hospital based fast neutron therapy facility in the United States. Over 300 
patients were treated.  
 
 
 
 
 
 
 
 
In 1975, the National Cancer Institute funded a 
neutron therapy facility at Fermilab using a 66 
MeV proton beam and a Beryllium target. 
(fig.26). Dosimetry of the neutron beam was 
carried in collaboration with the U of C.  Neutron 
dosimetry is complicated by the presence of 
gamma contamination.  Due to the difference in 
RBE and OER in the two components, (fig.21), it 
is necessary to determine both.  Typically, we 
use a pair of dosimeters, one made of TE 
materials, the other, non-hydrogenous, having 
low response to neutrons. The response of any dosimeter exposed to a mixed neutron plus 
gamma beam can be written as: 
 
R = h⋅Dγ  + k⋅Dn 
 
h and k are the response per unit tissue-dose for gammas and neutrons respectively.  h is usually 
determined in a Co-60 beam.  Both k and Dn are functions of neutron energy.  Dn is related to the 
neutron fluence Φ(E) by the tissue kerma factor, K(E).   
Figure 25. 
Deuterium gas target and cooling system1974. 
Figure 26. 
Fermilab Neutron Therapy Facility 
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Dn (E) = K(E)⋅Φ(E) and R = h⋅Dγ  + ∫ k(E)⋅K(E)⋅Φ(E)⋅d(E) 
 
If Dγ is zero, 
R = ∫ k(E)⋅K(E)⋅Φ(E)⋅d(E) 
 
R would be the response of the dosimeter to a “pure” neutron field characterized by the spectral 
distribution Φ(E).  
 
A “pure” neutron field can be obtained from a source that produces isotropic gamma and non-
isotropic neutron fields. This happens in photoneutron reactions as seen in our time-of-flight 
(ToF) measurements at Argonne.  
 
 The difference in measurements at two angles, ∆Ri is the equivalent of a measurement in a 
“pure” neutron field characterized by the difference in neutron fluence at these two angles, 
∆Φi(E)  
 
∆Ri =  ∫ k(E)⋅K(E) ⋅∆Φi(E) ⋅dE 
 
where i refers to a particular difference.  
 
We used the ToF data taken at Argonne for the Chicago 
beam but, for Fermilab.  We needed higher energies.  So 
we went to use the cyclotron at Princeton University to 
repeat the Argonne experiment. Seven “pure” neutron 
beams were obtained (fig.27).  Each difference spectrum 
is distinct from the others emphasizing different energy 
regions and there is good overlap of the individual 
spectra. We used three thimble ionization chambers with 
continuously flowing gas for measurements at the same 
angles at which ToF measurements were obtained. 
Chamber readings were subtracted to yield the response 
difference values, ∆Ri. 
 
A computer code developed at Oak Ridge National Lab. 
(ONL) for analysis of data from foil activation in reactors 
was used to solve the seven simultaneous equations for 
the function k(E)⋅K(E) (fig.28).  For each chamber, he 
input consisted of the seven values of ∆Ri together with the corresponding seven difference 
spectra Φi(E) and a trial solution for k(E)⋅K(E) as a starting point for the iterations.  The final 
Figure 27. 
Neutrons difference spectra. 
Phys. Med. Biol. v. 24, p. 721, 1979 
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Figure 29. Solutions for 
k(E). Phys. Med. Biol. v. 
24, p. 721, 1979. 
Figure 30. “They shall beat 
their swords into 
plowshares.” (Isaiah 2:4, 
Joel 3:10, Micah 4:3) 
 
 
results are shown in Figure 29. These became part of the AAPM 
Protocol for Neutron Dosimetry. 
 
The Fermilab Neutron Therapy Facility treated its first patient in 
1976. Funding was discontinued in 1985 when the facility 
became self-supporting. It is one of only three sites in the 
United States still offering neutron therapy.  To date, more than 
3000 patients have been treated at Fermilab. However, recently 
we learned that it is scheduled to close on June 30. The other 
two facilities are at the University of Washington in Seattle and 
at Wayne State University in Detroit.  Both have dedicated 
cyclotrons and state of the art 
equipment. 
 
Many of the developments I 
have described were made 
possible through collaboration of Universities, Research 
Laboratories and Industry and by the dedication of a number of 
pioneer physicists who, after working on the “Manhattan 
Project”, joined the “Atoms for Peace Effort” (fig.30).  This 
statue was donated by the Russian Government to the United 
Nations after World War II. The inscription is found three times 
in the Bible.  It also applies to the early developments of 
Medical Physics.  
Figure 28. Solutions for k(E)⋅K(E). Phys. Med. Biol. v. 24, p. 721, 1979. 
